Stocktwits on MSN
Sarepta hits fresh hurdle as court revives patent lawsuit with Regenxbio over muscular disorder therapy
Regenxbio filed a lawsuit in 2020 alleging that Elevidys infringed a gene-therapy patent that the company licenses from ...
Susan and Chris Finazzo have enrolled their sons Dylan and Chase in a study of gene therapy for Duchenne muscular dystrophy. The experimental treatment is still being studied but researchers hope it ...
Without finishing its Phase 3 clinical trial (usually, there are three phases), Sarepta sought a “fast-track” via conditional approval for a limited population and ultimately hoped to be able to treat ...
The first gene therapy for a deadly form of muscular dystrophy received preliminary U.S. approval on Thursday despite concerns from some government scientists about the treatment's ability to help ...
For genetic conditions like Duchenne muscular dystrophy, there is little doctors can do to slow or treat the condition other than trying to manage symptoms, since only addressing the genetic changes ...
Muscular dystrophy is *** debilitating condition affecting one's ability to move around the world. There is currently no cure for the disease which is why some are now turning to technology to live ** ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results